Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is frequently resistant to chemotherapy. However, epidermal growth factor receptor (EGFR) inhibition has demonstrated activity in HCC and overcomes chemotherapy resistance in other settings. We studied the efficacy of combining the anti-EGFR antibody cetuxi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sanoff, Hanna K., Bernard, Stephen, Goldberg, Richard M., Morse, Michael A., Garcia, Reynaldo, Woods, Lynna, Moore, Dominic T., O'Neil, Bert H.
Format: Artigo
Sprog:Inglês
Udgivet: International Society of Gastrointestinal Oncology 2011
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3201640/
https://ncbi.nlm.nih.gov/pubmed/22043322
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker